Literature DB >> 9358032

Bystander effects of different enzyme-prodrug systems for cancer gene therapy depend on different pathways for intercellular transfer of toxic metabolites, a factor that will govern clinical choice of appropriate regimes.

C Denning1, J D Pitts.   

Abstract

Transfer of suicide genes into tumor cells renders them sensitive to cytotoxic effects of specific prodrugs. We show here that both the herpes simplex virus thymidine kinase/ganciclovir (tk/GCV) and thymidine phophorylase/5'-deoxy-5-fluorouridine (tp/DFUR) suicide gene systems can induce cell death in tumor cells. Additionally in mixed cultures of cells with and without the suicide gene, death occurred in both cell types, indicative of a bystander effect. We demonstrate, in human and rodent cell lines, that the tk/GCV bystander effect requires gap junctional intercellular communication (GJIC). Where cultures lack GJIC, no bystander effect was observed. In communicating cultures, no correlation between level of GJIC and bystander effect was seen and this was due to high levels of tk activity. Additionally, we demonstrate that transfer of toxic metabolites from tk+ to tk- cells occurs within 2 hr of GCV application and, as no apoptosis could be detected until after this time, apoptosis is the result, not the cause, of the tk/GCV bystander effect. In the tp/DFUR system, a medium-mediated bystander effect, independent of GJIC and apoptosis, was observed. We demonstrated that combining tk/GCV and tp/DFUR suicide gene systems in culture was more effective than either therapy alone.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9358032     DOI: 10.1089/hum.1997.8.15-1825

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  17 in total

1.  Using intron splicing trick for preferential gene expression in transduced cells: an approach for suicide gene therapy.

Authors:  F Pourzadegan; L Shariati; R Taghizadeh; H Khanahmad; Z Mohammadi; M A Tabatabaiefar
Journal:  Cancer Gene Ther       Date:  2015-12-18       Impact factor: 5.987

2.  Understanding apoptotic signaling pathways in cytosine deaminase-uracil phosphoribosyl transferase-mediated suicide gene therapy in vitro.

Authors:  P Gopinath; Siddhartha Sankar Ghosh
Journal:  Mol Cell Biochem       Date:  2008-12-14       Impact factor: 3.396

Review 3.  Radiation-induced bystander signalling in cancer therapy.

Authors:  Kevin M Prise; Joe M O'Sullivan
Journal:  Nat Rev Cancer       Date:  2009-04-20       Impact factor: 60.716

4.  TK gene combined with mIL-2 and mGM-CSF genes in treatment of gastric cancer.

Authors:  Shan-Yu Guo; Qin-Long Gu; Zheng-Gang Zhu; He-Qun Hong; Yan-Zhen Lin
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

5.  Gap junctions and Bystander Effects: Good Samaritans and executioners.

Authors:  David C Spray; Regina Hanstein; Sandra V Lopez-Quintero; Randy F Stout; Sylvia O Suadicani; Mia M Thi
Journal:  Wiley Interdiscip Rev Membr Transp Signal       Date:  2012-12-11

6.  BR96-DOX immunoconjugate targeting of chemotherapy in brain tumor models.

Authors:  Leslie L Muldoon; Edward A Neuwelt
Journal:  J Neurooncol       Date:  2003-10       Impact factor: 4.130

7.  Prodrugs for Gene-Directed Enzyme-Prodrug Therapy (Suicide Gene Therapy).

Authors:  William A. Denny
Journal:  J Biomed Biotechnol       Date:  2003

8.  Targeting Radiotherapy to Cancer by Gene Transfer.

Authors:  R. J. Mairs; M. Boyd
Journal:  J Biomed Biotechnol       Date:  2003

9.  Gene-Directed Enzyme Prodrug Therapy by Dendrimer-Like Mesoporous Silica Nanoparticles against Tumor Cells.

Authors:  Vicente Candela-Noguera; Gema Vivo-Llorca; Borja Díaz de Greñu; María Alfonso; Elena Aznar; Mar Orzáez; María Dolores Marcos; Félix Sancenón; Ramón Martínez-Máñez
Journal:  Nanomaterials (Basel)       Date:  2021-05-14       Impact factor: 5.076

10.  Exploiting the Intron-splicing Mechanism of Insect Cells to Produce Viral Vectors Harboring Toxic Genes for Suicide Gene Therapy.

Authors:  Haifeng Chen
Journal:  Mol Ther Nucleic Acids       Date:  2012-11-27       Impact factor: 10.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.